Chung Christine's Form 4 filing
Kyntra Bio, Inc. (KYNB) · filed Dec 9, 2022
- Accession no.
- 0001209191-22-060582
- Filed
- Dec 9, 2022
- Trade date
- Dec 8, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $17.3K. It was filed 1 day after the trade.
This filing was later replaced by the amendment 0001209191-23-001354 (Jan 4, 2023). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Chung ChristineCIK 0001775295 | Officer (SVP, China Operations) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 8, 2022 | Common Stock | SSaleDisposed | −1,096 | $15.79 | −$17,305.84 | 237,705 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.